Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling ...

The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

Biotech headwinds are driving double-digit revenue growth and profitability for these two mid-caps.

So far this month, investors have poured $2.6 billion into follow-on rounds for public biotechs — the most ever for the ...

And, if all goes well, over the next five years as well.

Amid the expected positive clinical trial results, Legend Biotech has also reiterated plans to achieve profitability in 2026.

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

Healthcare stocks rallied in 2025, breaking a two-year slump as investors chased steadier rates, better valuations, and ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Uncover the systematic approach to biotech firm valuation using DCF. Equip yourself with the knowledge to gauge company ...

Stay updated on biotech layoffs in 2026! Each week, we track and analyze industry layoffs, their causes, and their impact.